Tender Title: RESPIRATORY DRUGS
Reference Number: 17780153d
Issuing Authority/Department:
Department of Military Affairs, Ministry of Defence
Scope of Work and Objectives
The primary objective of this tender is to procure quality respiratory drugs. The tender encompasses the supply of essential medications, specifically N-Butyl Cyanoacrylate 0.5 ml injection, Diphenhydramine Syrup containing 10 to 15 mg per 5 ml, and Ammonium Chloride. The total quantity required is 13,960 units. Vendors are invited to submit their quotes for these specific pharmaceutical products to ensure the department can meet its medicinal supply needs efficiently and adequately.
Eligibility Criteria
To be eligible to participate in this tender, the bidders must meet the following criteria:
- Be a registered entity with valid documentation.
- Demonstrate experience in supplying pharmaceutical products.
- Possess all necessary certificates and licenses to distribute drugs as per regulatory standards.
- Meet the technical requirements set forth in this tender document.
Technical Requirements
Bidders must ensure that:
- All respiratory drugs supplied must conform to the prescribed standards of quality and safety as outlined by regulatory authorities.
- Technical specifications, such as dosage forms and active ingredients, must comply with the requirements specified within the tender.
Financial Requirements
Bidders should be prepared to demonstrate their financial stability and capacity to fulfill the tender. This may include, but is not limited to:
- Audited financial statements.
- Evidence of work with similar contracts in terms of value.
Document Submission Details
All requisite documents should be submitted electronically. Specific attention should be paid to ensure that every document is formatted correctly, complete, and submitted before the closing date of the tender process.
Special Provisions
Supporting Micro, Small, and Medium Enterprises (MSEs) and startups is an essential aspect of this tender. Relevant stakeholders may benefit from provisions designed to create equitable opportunities in the procurement process. MSEs can find encouragement in policies promoting local manufacturing, which may lead to additional points during evaluation.
Evaluation Process
Bids will be evaluated based on various criteria, including:
- Compliance with eligibility and technical requirements.
- Financial viability.
- Adherence to submission protocols.
- Pricing, including consideration of local content and other advantages offered by MSEs and startups.
Delivery Locations
The delivery locations will be specified within the tender document, where adherence to scheduled timelines for delivery will be essential for contract fulfillment.
Contact Information
For additional clarifications, interested bidders may contact the Department of Military Affairs through the listed communication channels within the tender documentation.
Conclusion
Participation in this tender presents a unique opportunity for qualified suppliers to establish partnerships with government entities. By delivering high-quality pharmaceutical products, suppliers can contribute significantly to public health initiatives while benefiting from a stable source of procurement contracts.
Tender BOQ Items
9 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
7 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, holding necessary licenses and certificates to distribute pharmaceutical products, and demonstrating a history of fulfilling similar contracts. Additionally, bidders must comply with the technical requirements set in the tender, ensuring that their products meet quality and safety standards outlined by regulatory authorities.
Participants must possess pertinent certifications related to drug distribution and quality compliance, including licenses from drug regulatory authorities. Furthermore, documentation proving compliance with local manufacturing standards and any specific certificates stipulated in the tender document must be provided.
To participate, prospective suppliers must follow the registration guidelines outlined in the tender document. This involves submitting proof of registration as an entity, followed by adherence to specified submission formats for documents. Vendors are encouraged to verify their documents and register well ahead of submission deadlines to facilitate a smooth bidding process.
Payment terms will be clearly detailed within the tender document, typically comprising criteria such as invoicing procedures, payment timelines post-delivery, and arrangements for deposits such as Earnest Money Deposit (EMD) as required. It is crucial for bidders to comprehend these terms to align their financial planning accordingly.
Yes, there are specific provisions designed to support MSEs in this tender process. These include opportunities for enhanced evaluation preferences, local content advantages, and potential financial incentives aimed at promoting equal competition amongst larger enterprises. Compliance with policies promoting local manufacturing may further enhance the benefits available to MSEs.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders